| 03 Sep 2010 |
|
Fresenius Medical Care and SEHA Enter Into Exclusive Agreement to Serve Dialysis Patients in Abu Dhabi
- Text size
BAD HOMBURG, Germany, September 3, 2010/PRNewswire/ -- Fresenius Medical Care AG & Co. KGaA (Frankfurt Stock Exchange: FME / New York Stock Exchange: FMS), the world's largest provider of dialysis products and services, today announced its signing of a nonbinding memorandum of understanding with Abu Dhabi Health Services Co. PJSC (SEHASEHA
), the public provider of health care services, for exclusive management of its dialysis facilities in the emirate of Abu Dhabi, United Arab Emirates. The agreement will enable Fresenius Medical Care to initiate activities in a key Middle Eastern market. It also is aimed as a key aspect of both groups' strategy to expand their business in the region. Both entities have agreed not to disclose financial details of the transaction under discussion.
"Initiating patient care operations in the Middle East has been a defined path in our overall growth strategy, and we are convinced that the contract with SEHASEHA
is an excellent basis for the growth of Fresenius Medical Care in this region. The contract will allow our company to significantly strengthen its sales and distribution network and expand our presence in this key market," said Fresenius Medical Care's Dr. Emanuele Gatti, CEO for Europe, Latin America, the Middle East and Africa. Saif Bader Al Qubaisi, managing director and chairman of SEHASEHA
, commented, "We are delighted to have engaged Fresenius Medical Care as our exclusive partner in the management of our renal patients. We look forward to benefiting from the knowledge and skills of the leader in this sector in building a world-class patient care organization that delivers on its promise of high-quality health care services for the people. We also look forward to pursuing other development activities in the region with our partner Fresenius Medical Care." Dr. Ali Abdulkareem Al Obaidli, chief of clinical affairs for SEHASEHA and a practicing renal specialist, added, "This is good news for Abu Dhabi. Bringing in the world's best providers and managers is part of our business strategy. This partnership will result in improved service levels and better outcomes for our dialysis patients."
For more information about Fresenius Medical Care, visit the company's website at http://www.fmc-ag.com.
- Ends -
About the SEHASEHA HealthSystem and Abu Dhabi Health Services Co. PJSC (SEHASEHA)
Abu Dhabi Health Services Co. PJSC is an independent, public joint-stock company wholly owned by the government of Abu Dhabi and created to develop the curative activities of the emirate's public health care system. The company owns and operates all the public hospitals and clinics in the emirate of Abu Dhabi which together make up the SEHASEHA HealthSystem. Its holdings include 12 hospitals with 2,644 beds, 62 ambulatory care, family care and urgent care centers and two blood banks. SEHASEHA is one of the largest integrated health care providers in the Middle East, employing 16,500 doctors, nurses, ancillary care and administrative personnel. SEHASEHA means "health" in Arabic. Visit the SEHASEHA website at http://www.seha.ae.
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including changes in business, economic and competitive conditions, regulatory reforms, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.
For more information, please contcat:
Joachim Weith
Corporate Communications and Governmental Affairs
Tel.: +49-6172-6082101
+49-6172-6082101
Fax: +49-6172-6082294
E-mail: pr@fmc-ag.com
http://www.fmc-ag.com
Source: Fresenius Medical Care AG & Co. KGaA
© Press Release 2010
Zawya is a distributor (and not a publisher) of content supplied by third parties and subscribers. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by those third parties, including information providers, subscribers or other users of the Service, are those of the respective author(s) or distributor(s) and not of the Company. The Company neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Service by anyone other than authorized Service employee spokespersons while acting in their official capacities. The Company is not responsible for any infringement of intellectual property rights or breach of any applicable law or regulation, including regulation in relation to financial services or the distribution of financial products, defamation, data protection, telecommunications (including regulations relating to excessive use, spamming or other abusive activities) or obscene, offensive or illegal content). Under no circumstances will the Company be liable for any loss or damage caused by a member's reliance on information obtained through the Service. It is the responsibility of member to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Service. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.
Read the full Member Agreement
http://www.zawya.com/legal/NewsLetter.cfm?name=disclaimer
Loading ...
Post a Comment
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another's privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse.